Patent ID: 7097854

Claim:
A composition comprising a compound of formula (I) wherein A is selected from the group consisting of hydrogen, a group NR 1 R 2 , a group NR 1 (CH 2 ) p NR 3 R 4 , a group (C═NH)NH 2 and a pyridinyl residue; B and D are each independently selected from the group consisting of a bond, a C 1 –C 6 alkylene residue and a group NR 5 —(C 2 to C 6 alkylene); J is selected from the group consisting of piperidinediyl and piperazinediyl; W and X are each independently selected from the group consisting of a bond and a carbonyl group; Y and Z are each independently a saturated or unsaturated C 7 –C 24 hydrocarbon residue; R 1 –R 5 are each independently selected from the group consisting of hydrogen and a C 1 –C 6 alkyl residue; m is 0, 1 or 2, wherein when m is 2, the two residues J are identical to or different from each other; n and o are each independently 2, 3 or 4; and p is 2–6, or a physiologically tolerated salt thereof, and that m is other than 0 when A is either hydrogen or a group (C═NH)NH 2 and B and D are each independently a bond or an alkylene residue, wherein the composition further comprises a therapeutic agent.